Tagcloud

ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome

MIMS Ireland: December 2008

Acomplia (rimonabant)

IMB, Acomplia, rimonabant | 01 December 2008 | Irish Medicines Board

The Irish Medicines Board (IMB) suspended the marketing and use of Acomplia in Ireland on 23rd October 2008 following a recommendation issued by the European Medicines Agency (EMEA) on the same date. This national action was taken following review of... Read more

Exforge-based therapy in difficult-to-treat, black patients

01 December 2008 | New Clinical Evidence

Significant blood pressure reductions is obtained in difficult-to-treat, black patients receiving Exforge-based therapy.... Read more

Rasilez ASPIRE HIGHER

01 December 2008 | New Clinical Evidence

Rasilez ASPIRE HIGHER cardio-renal outcomes program expands to 35,000 patients in 14 trials... Read more

Canazole

01 December 2008 | New Products

Company: Pinewood Healthcare. Legal category: Pharmacist only. GMS. Sport Permitted. Active ingredient: Clotrimazole 1%. Description: White cream. Presentation: 20g, €4.48 (20g not GMS reimbursable); 50g, €4.00. Indications: Treatment of fungal skin infections due to Candida, most commonly Candida albicans. Mucocutaneous... Read more

Donesyn

01 December 2008 | New Products

Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Donepezil (hydrochloride) 5mg, 10mg. Description: White or yellow round biconvex film-coated tablets marked D9EI on one side and 5 or 10 on reverse respectively. Presentation: 5mg-28, €52.53, 10mg-28,... Read more

Durolane

01 December 2008 | New Products

Company: Smith & Nephew Ltd. Legal category: Medical device. Active ingredient: Non-animal, stabilised, hyaluronic acid (NASHA) 60mg. Description: Sterile, transparent viscoelastic gel supplied in a 3ml glass syringe. Presentation: 20mg/ml-1, €307. Indication: Symptomatic treatment of mild to moderate knee or... Read more

Finocar

01 December 2008 | New Products

Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport prohibited. Active ingredient: Finasteride 5mg. Description: Light blue spherical biconvex film-coated tablet. Presentation: 28, €22.76. Indications: Treatment and control of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate (prostate volume... Read more

Laxido Orange

01 December 2008 | New Products

Company: Galen Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Macrogol 3350 13.125g, sodium chloride 350.7mg, sodium hydrogen carbonate 178.5mg, potassium chloride 46.6mg. Description: Free flowing white powder for oral solution in a single-dose sachet. Presentation: 30, €7.68. Indications:... Read more

Mobicam

01 December 2008 | New Products

Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Meloxicam 7.5mg, 15mg. Description: Pale yellow round tablet scored on one side. Presentation: 7.5mg-30, €8.46; 15mg-30, €11.85. Indications: Short-term symptomatic treatment of exacerbations of osteoarthrosis. Long-term symptomatic treatment of... Read more

Rispal

01 December 2008 | New Products

Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Risperidone 0.5mg, 1mg, 2mg, 3mg. Description: Respectively red-brown, white, peach and yellow round biconvex film-coated tablets. 0.5, 1 and 2mg scored. Presentation: 0.5mg-20, €8.75; 1mg-60, €34.08; 2mg-60, €67.24; 3mg-60,... Read more

Tyverb

01 December 2008 | New Products

Company: GlaxoSmithKline (Ireland) Ltd. Legal category: HT. Sport permitted. Active ingredient: Lapatinib ditosylate monohydrate, eq. to 250mg lapatinib. Description: Oval, biconvex, yellow film-coated tablets, with GS XJG debossed on one side. Presentation: 70, price available on request. Indications: In combination... Read more

Vedixal

01 December 2008 | New Products

Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Venlafaxine (as hydrochloride) 37.5mg, 75mg. Description: Respectively pale red-brown oblong tablet, coded 3 and pale red-brown oblong scored tablet, coded 7 on each half. Presentation: 37.5mg-56, €18.07; 75mg-56, €30.13.... Read more

Vedixal XL

01 December 2008 | New Products

Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Venlafaxine (as hydrochloride) 37.5mg, 75mg, 150mg. Description: Respectively, light grey, flesh-coloured and orange prolonged-release hard capsules containing white to off-white pellets. Presentation: 37.5mg-7, €3.04; 75mg-28, €17.47; 150mg-28, €29.45. Indications:... Read more

Warfarin Teva

01 December 2008 | New Products

Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Warfarin (sodium) 1mg, 3mg. 5mg. Description: Brown, blue, pink flat, capsule shaped, scored tablets with WARFARIN on top of TARO engraved on one side and 1, 3, 5... Read more

Amoclav Suspension

01 December 2008 | New Presentations

Company: Rowex Ltd. Legal category: Prescription. GMS. Sport Permitted. Active ingredients: Amoxycillin (as amoxycillin trihydrate)125mg, clavulanic acid (as potassium clavulanate) 31.25mg. Description: Off-white granules for oral suspension. Presentation: 100ml-1, €3.63. Indications: Short term treatment of bacterial infections of the upper... Read more

Hycamtin Capsules

01 December 2008 | New Presentations

Company: GlaxoSmithKline. Legal category: HT. Sport permitted. Active ingredient: Topotecan 0.25mg, 1mg. Description: Respectively, opaque white to yellowish white or opaque pink hard capsule imprinted with HYCAMTIN and strength. Presentation: 0.25mg-10; 1mg-10. Prices available on request. Indications: Monotherapy for the... Read more

Infanrix Hexa

01 December 2008 | New Presentations

Company: GlaxoSmithKline (Ireland) Ltd. Legal category: Prescription. Sport permitted. Active ingredient: Diphtheria toxoid ≥ 30IU; tetanus toxoid ≥ 40IU; pertussis toxoid 25mcg, filamentous haemagglutinin 25mcg, pertactin 8mcg; hepatitis B surface antigen 10mcg; inactivated poliovirus type 1 40D-antigen unit, type 2... Read more

New Packaging for Symbicort Turbohaler

01 December 2008 | New this Month

AstraZeneca Pharmaceuticals wish to inform you of a change in packaging for Symbicort Turbohaler (formoterol/budesonide). The new packs are for all strengths of Symbicort (100/6, 200/6, 400/12). Features of the new pack include new font, design and colours that will... Read more

Discontinuation of Alupent Expectorant Mixture

01 December 2008 | Discontinued Products

Boehringer Inghelheim Ireland Ltd wishes to advise you that Alupent Expectorant Mixture will be discontinued on 31st January 2009. Alupent Syrup and Bisolvon are unaffected by this discontinuation and will remain available. These two products may be used at the... Read more

Discontinuation of Clarosip

01 December 2008 | Discontinued Products

Grunenthal Pharma Ltd regrets to announce the discontinuation of Clarosip 125mg, 187.5mg and 250mg clarithromycin granules for oral suspension from 24th November 2008. They regret the inconvenience that this may cause and refer physicians to suitable alternatives that remain available.... Read more

Discontinuation of Diamicron 80mg

01 December 2008 | Discontinued Products

Servier Laboratories wish to announce the withdrawal of Diamicron 80mg. Stock of Diamicron 80mg will be completely withdrawn by December 2008. Prescribers are advised to prescribe Diamicron MR as an alternative to Diamicron 80mg from 30th November 2008. Diamicron MR... Read more

Discontinuation of Dynepo

01 December 2008 | Discontinued Products

In agreement with the Irish Medicines Board, Shire plc wishes to advise you of the discontinuation of Dynepo. Dynepo is an erythropoiesis-stimulating agent (ESA) indicted for the treatment of symptomatic anaemia associated with chronic renal failure in adult patients.Dynepo will... Read more

Discontinuation of NeoRecormon

01 December 2008 | Discontinued Products

Roche Products (Ireland) Ltd wishes to inform you of the discontinuation of three of its products, NeoRecormon 10,000 IU lyophilisate and solvent for solution for injection in cartridge (pack size of 1), NeoRecormon 20,000 IU lyophilisate and solvent for solution... Read more

Discontinuation of Poliomyelitis Vaccine (Oral) Live

01 December 2008 | Discontinued Products

GlaxoSmithKline (Ireland) Ltd wishes to inform you that the Poliomyelitis Vaccine (Oral) Live has been discontinued and will no longer be available after 30th November 2008.... Read more

Discontinuation of Teoptic Eye Drops

01 December 2008 | Discontinued Products

Novartis Ireland Ltd announces the discontinuation of both strengths and packs of Teoptic Eye Drops from January 2009 as follows: Teoptic drops 1%-5 ml & 3 × 5ml and Teoptic drops 2%-5 ml & 3 × 5ml.... Read more